Stem Cells: Clinical Trials

6 trials for Stem Cells, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 2 withdrawn, 1 completed, 1 not yet recruiting. 6 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Unknown 2, Withdrawn 2, Completed 1, Not yet recruiting 1
Phase 21Not yet recruiting 1

Follow Stem Cells: new trials by email Literature Review of Stem Cells trials Research Report on Stem Cells

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Repeated Injections of Adipose-derived Stem Cells in Rotator Cuff Tears
Adipose derived stem cell injection, Placebo - Rotator Cuff Tears, Rotator Cuff Injuries
Phase 1 / Phase 2Not yet recruitingUniversity of Southern Denmark302026-10-012026-09-30
AlloGeneic Human Mesenchymal Stem Cells (hMSC) in PAtients With FistuLizing Crohn's Disease Via PErifistula iNjEctions (GALENE)
Allogeneic Bone Marrow derived Human Mesenchymal Stem Cells (hMSCs) - Crohn's Disease, Fistulizing Crohn's Disease
Phase 1WithdrawnJoshua M Hare2019-12-012026-01-27
Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth
Allogeneic adipose derived stem/stromal cells - Xerostomia Due to Radiotherapy, Hyposalivation
Phase 1UnknownCopenhagen University Hospital, Rigshospitalet102019-03-182021-01-29
Safety Study of Stemchymal® in Acute Liver Failure
Stemchymal® - Stem Cells, Adult Stem Cells
Phase 1WithdrawnSteminent Biotherapeutics Inc.2018-10-012022-10-28
Intracavernous Injection of Autologous Mesenchymal Stem Cells in the Treatment of Erectile Dysfunction Resistant to Oral Treatment in Patients With Type I Diabetes
Autologous Bone Marrow derived Mesenchymal Stem Cells - Erectile Dysfunction, Stem Cells
Phase 1UnknownCentral Hospital, Nancy, France132018-06-302017-12-05
Stem Cells After Peripheral Mobilization and Harvest
Filgrastim Injection - Stem Cells, Orthopedic Disorder
Phase 1CompletedAndrews Research & Education Foundation102018-03-282020-03-06

Narrower conditions

Acute-On-Chronic Liver Failure (1)  ·  Crohn Disease (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Erectile Dysfunction (1)  ·  Liver Failure, Acute (1)  ·  Musculoskeletal Diseases (1)  ·  Oropharyngeal Neoplasms (1)  ·  Rotator Cuff Injuries (1)  ·  Salivary Gland Diseases (1)  ·  Xerostomia (1)

Broader conditions

Digestive System Diseases (2)  ·  Autoimmune Diseases (1)  ·  Diabetes Mellitus (1)  ·  Endocrine System Diseases (1)  ·  Gastroenteritis (1)  ·  Gastrointestinal Diseases (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Male (1)  ·  Glucose Metabolism Disorders (1)  ·  Head and Neck Neoplasms (1)  ·  Hepatic Insufficiency (1)  ·  Immune System Diseases (1)  ·  Inflammatory Bowel Diseases (1)  ·  Intestinal Diseases (1)  ·  Liver Diseases (1)

Interventions

Filgrastim (1)

Sponsors

Andrews Research & Education Foundation (1)  ·  Central Hospital, Nancy, France (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Joshua M Hare (1)  ·  Steminent Biotherapeutics Inc. (1)  ·  University of Southern Denmark (1)

Countries

Denmark (1)  ·  Taiwan (1)  ·  United States (1)

Top investigators

Adam W Anz, MD (1)  ·  Charlotte Lynggaard, MD (1)  ·  David Kerman, MD (1)  ·  Lars Frich (1)  ·  Michael Goodlett, MD (1)

NIH funding

2018 (1)